Varenicline as a smoking cessation aid in a Greek population: a subanalysis of an observational study
Background Greece has the highest proportion of smokers in the European Union with 42% of Greeks admitting that they smoke, based on a 2009 survey. This post-hoc analysis of a prospective, observational study evaluated the effectiveness and safety profile of the smoking cessation aid varenicline, as...
Main Authors: | Christina Gratziou, Konstantinos I. Gourgoulianis, Paraskevi Argyropoulou Pataka, Georgia D. Sykara, Michael Messig, Sunil Raju |
---|---|
Format: | Article |
Language: | English |
Published: |
European Publishing
2012-02-01
|
Series: | Tobacco Induced Diseases |
Subjects: | |
Online Access: | http://www.journalssystem.com/tid/Varenicline-as-a-smoking-cessation-aid-in-a-Greek-population-a-subanalysis-of-an-observational-study,66081,0,2.html |
Similar Items
-
Varenicline and evaluated outcomes in smoking cessation programmes
by: P. Santus, et al.
Published: (2015-11-01) -
A comparison of the efficacy of varenicline and bupropion and an evaluation of the effect of the medications in the context of the smoking cessation programme
by: Ali Ramazan Benli, et al.
Published: (2017-02-01) -
Varenicline treatment for smoking cessation in high risk patients: a budget impact analysis
by: Federico Spandonaro, et al.
Published: (2017-10-01) -
A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trial
by: Baker CL, et al.
Published: (2018-01-01) -
Varenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherence
by: Burke MV, et al.
Published: (2016-04-01)